MedTrace Logo

Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension

NCT00693199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2008-08-08

No results posted yet for this study

Summary

The aim of this study was to investigate the efficacy and safety of low dose amlodipine alone, or combined with low dose terazosin in male patients with both lower urinary tract symptoms and hypertension.

Conditions

Interventions

DRUG

amlodipine

amlodipine 5mg once daily for 28 days

DRUG

terazosin

terazosin 2 mg once daily for 28 days

DRUG

amlodipine plus terazosin

amlodipine 5 mg plus terazosin 2 mg once daily for 28days

Sponsors & Collaborators

  • The University of Science and Technology of China

    collaborator OTHER

  • Peking University First Hospital

    collaborator OTHER

  • Anhui Medical University

    lead OTHER

Principal Investigators

  • Ping Liu, PhD · Biomedical Institute of Anhui Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2006-10-31
Completion
2006-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00693199 on ClinicalTrials.gov